Masimo Radical-7(r) with First-Ever Noninvasive and Continuous Hemoglobin (SpHb(r)) Monitoring Technology Shown to Reduce Blood Transfusions 86%. SpHb measurement (highlighted in the photo) provides immediate, continuous hemoglobin results without the invasive blood draw and time-consuming lab process associated with traditional blood testing-enabling real-time tracking and trending of hemoglobin levels for the first time(shown in the bottom waveform).
First randomized controlled trial study results on noninvasive and continuous hemoglobin monitoring technology show it cuts the need for and frequency of blood transfusions by 86% and the amount transfused by 90% during surgery!
Would you eat a 30-day-old steak that’s been sitting in the refrigerator for dinner? Most people wouldn’t dream of putting food that old into their bodies. But, if you are one of the 10 million patients having surgery this year, chances are you may be putting blood that’s over 30 days old into your body…with potentially deadly repercussions.
Mounting evidence has shown that blood transfusions significantly increase morbidity and mortality by up to 38%. When necessary, there is no question that blood transfusions can save lives. But unnecessary blood transfusions are causing unnecessary deaths and serious complications that burden our healthcare system…unnecessarily. Receiving stale blood and its physiological impact on your body systems and health state are just two of the known risks that make blood transfusions seriously risky business. But according to the results of a new study presented at the ASA today, a new nonivasive medical technology could help significantly reduce your likelihood of receiving a blood transfusion altogether.
Using a new noninvasive and continuous hemoglobin (SpHb) monitoring technology developed by Masimo, researchers at MGH, Harvard Medical School, and Vanderbilt University Medical Center were able to dramatically reduce the need for and frequency of blood transfusions administered during surgery by 86%–proving that with the right technology, unnecessary blood transfusions and their risks can be safely avoided. And, when a transfusion was a lifesaving necessity during surgery, noninvasive hemoglobin monitoring helped researchers to transfuse more conservatively–reducing the amount of blood transfused by 90% to help lower the likely risk and impact of transfusion-related complications.
This is a major advancement in both science and patient care as doctors have been waiting for a way to immediately, continuously, and noninvasively measure hemoglobin so that they would absolutely know when to transfuse and when not to–without having to guess or waste precious minutes waiting on lab results. Now if you or a loved one were having surgery, wouldn’t you feel safer knowing that there is a noninvasive and cost-effective way to ensure you would be transfused blood ONLY when absolutely necessary and ONLY in the amount you truly needed (and no more). The 10 million Americans having surgery this year sure could benefit from this news and this technology advancement!
